In Asia Pacific, China is a key player in the microarray market, with rapid infrastructure development and a growing focus on genomics research. Japan is another prominent market, with strong technological capabilities and a prominent presence of key market players. South Korea is also emerging as a significant market, with a growing focus on biotechnology research and collaborations with global players.
In Europe, the United Kingdom leads the microarray market with a strong emphasis on genomics research and increasing adoption of personalized medicine. Germany is another major market, with a robust healthcare system and significant investments in research and development. France is also a key player in the market, with a high prevalence of chronic diseases driving the demand for advanced molecular diagnostics tools.